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Comments on "Estrogenicity
of Resin-based Composites
and Sealants Used in
Dentistry"
Considerable concerns about bisphenol A
(BPA) as a potential endocrine disruptor
remain controversial among dentists and
patients due to the study ofOlea et al. (1).
Their study has frequently been mentioned
in scientific papers as well as in the mass
media, popular journals, and books. When
I read the paper, I was shocked to find
unscientific data related to high perfor-
mance liquid chromatography (HPLC)
analysis. I am concerned about continued
reference to this study. Ashby (2) com-
mented on the study in a letter in EHP
titled "Bisphenol-A Dental Sealants: The
Inappropriateness of Continued Reference
to a Single Female Patient," but I feel his
comments are insufficient.
Olea et al. (1) reported that 90-931 pg
of BPA was identified in saliva collected
from 18 subjects treated with 50 mg of a
bisphenol A diglycidyl methacrylate (bis-
GMA)-based sealant on molars during a 1-
hr period after treatment. However, based
on data presented in their Table 1, this is
unlikely. According to Table 1 (1), 50 mg
ofthe sealant should contain 3.7 pgofBPA
or 78.7 pg of a mixture of bis-GMA,
bisphenol A diglycidyl ether (BADGE),
bisphenolAdimethacrylate (BPDMA), and
BPA. This mixture (78.7 pg) is equivalent
to 48.2 pg of BPA. Assuming that all the
components of the mixture leached into
the saliva uncured and were degraded com-
pletely to BPA within 1 hr, the amount of
BPA collected from the saliva should be
48.2 pg. However, their Table 2 (1)
showed 1.9-19.3-fold higher values than
expected (89.9-931.0 pg).
In the "Results," Olea etal. (1) reported
that
A subject initially selected for treatment had been
treated with tooth sealant 2 years earlier; chro-
matograms demonstrated the presence ofbisphe-
nol-A (66.4 pg) and bisphenol-A dimethacrylate
(49.2 pg) in her saliva before the second treat-
ment. The results from this subject were excluded
from analysis.
This finding suggested that 66 pg/hr of
BPA may be continually released over 2
years. This is unlikely because the treat-
ment would have been practically impossi-
ble. Assuming that 66 pg of BPA leached
into the saliva daily, leaching of BPA
would have constituted 48.2 mg over 2
years. The BPA content in the sealant was
0.0074% according to their data.
Therefore, the original amount of sealant
used would have been about 650 g. Even if
BPDMA, which is easily hydrolyzed to
BPA, is included in the calculation, it
would have been approximately 200 g.
In their Table 1, Olea et al. (1) indicat-
ed that the amount ofethanol-soluble com-
ponents in the composite resins and the
sealant was 0.03-0.19% (calculated from
the total weight offour components shown
in Table 1 contained in 100 mg of com-
mercial product). These values are much
too small because commercial resins usually
contain 15-50% of ethanol-soluble com-
ponents. Olea et al. (1) stated that
these commercial formulations contain a large
proportion of inorganic filler particles (50-85%
byweight ofthe composite).
Moreover, they did not refer to triethyl-
ene glycol dimethacrylate (TEGDMA),
which is a major component in all these
commercial products. Assuming that their
data were correct, some questions arise: a)
BPA contents in the ethanol-soluble compo-
nents [most ofwhich consist ofa mixture of
bis-GMA (and BPDMA) and TEGDMA]
were much too high-1.7-35.2% (calculat-
ed from the ratio ofBPA to the total weight
of four components). Such impure
monomers are unlikely in the chemical
industry at the present time. BPA may exist
in the monomers as an impurity. b) The
total amounts of ethanol-soluble compo-
nents markedly increased or decreased in
many cases after hydrolysis in alkaline or
acidic media beyond the values expected
from the contents before hydrolysis. This
should not occur in a chemical reaction; the
reaction should follow the law of conserva-
tion ofmass. c) The increase in the BPDMA
content in alkaline media for composites 1
and 2 is unlikely because it is easily
hydrolyzed to BPA in the media. a) The
marked increase in bis-GMA content after
hydrolysis in acidic or alkaline media, com-
posite 3, is unlikely because bis-GMA is
hydrolyzed undersuch conditions.
The calculation presented in Olea and
colleagues' Table 2 (1) is difficult to
understand. The saliva volume multiplied
by the concentration of BPA should be
equal to the total amount ofBPA in saliva.
None of the data presented in their Table
2 supported this arithmetic.
Olea et al. (1) may have misunderstood
that BPA (as well as BADGE) constitutes
components of resins, judging from the
statement in the first paragraph of the
"Discussion":
... we demonstrate that [BPA] and [BPDMA],
components ofcommercial resin-based compos-
ites and sealants used in dentistry, are estro-
genic ....
BPA and BADGE are not components,
but only a trace amount ofthese materials
is contained as impurities in bis-GMA
and/or BPDMA monomers. Therefore, the
amount ofleached BPA is extremely small
or not detectable, as reported recently by
other investigators (3-5). On the other
hand, BPDMA is a component of the
sealant used in their study. Therefore,
leaching ofa small amount ofunpolymer-
ized BPDMA is likely (3,4). Furthermore,
the detection of BPA derived from
BPDMA in saliva is likely because
BPDMA is easily hydrolyzed to BPA in
saliva (6). Thus, it is reasonable to assume
that most ofthe BPA identified in saliva by
Olea et al. (1) can be attributed to leached
BPDMA. Therefore, the use of BPDMA
should be extensively examined.
Data relevant to HPLC analysis pre-
sented by Olea et al. (1) are not reliable.
These data should be corrected or with-
drawn, and further reference to this data
should be avoided.
Yohji Imai
Institute for Medical and
Dental Engineering
Tokyo Medical and Dental University
Tokyo, Japan
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Olea's Response
Imai seems to be upset about our recom-
mendation to curtail the use of bisphenol
A-based sealants and daims to have found
unscientific data among our HPLC results.
His opinions appear to be based on a poor
reading ofour study (1) and what he refers
to as "relevant papers." Unfortunately, Imai
reveals no data of his own and reports no
experiments or time spent actuallytrying to
solve this problem.
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